Vyant Bio, Inc.
News
Critical Analysis: Vyant Bio (NASDAQ:VYNT) & Aclarion (NASDAQ:ACON)
Ticker Report Vyant Bio (NASDAQ:VYNT Get Rating) and Aclarion (NASDAQ:ACON Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation...\n more…
Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration
Globe Newswire CHERRY HILL, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (Vyant Bio or Company) (Nasdaq: VYNT) is a biotechnology company that incorporates innovative biology and data scienceto improve drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Companys proprietary...\n more…
Vyant Bio, Inc. (NASDAQ:VYNT) Short Interest Update
Ticker Report Vyant Bio, Inc. (NASDAQ:VYNT Get Rating) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 204,700 shares, a growth of 28.3% from the April 15th total of 159,500 shares. Currently, 4.1% of the companys shares are ...\n more…
Vyant Bio Announces Voluntary Nasdaq Delisting and SEC Deregistration
Globe Newswire CHERRY HILL, N.J., April 24, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (Vyant Bio or Company) (Nasdaq: VYNT) is a biotechnology company that incorporates innovative biology and data science to improve drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Companys ...\n more…
Vyant Bio (NASDAQ:VYNT) Trading Down 1.5%
Ticker Report Vyant Bio, Inc. (NASDAQ:VYNT Get Rating)s stock price traded down 1.5% during mid-day trading on Friday . The stock traded as low as $0.62 and last traded at $0.65. 19,362 shares were traded during trading, a decline of 96% from the average session volume of 453,512 shares. The stock ...\n more…
Vyant Bio, Inc. (NASDAQ:VYNT) Short Interest Up 17.4% in February
Ticker Report Vyant Bio, Inc. (NASDAQ:VYNT Get Rating) saw a large growth in short interest in February. As of February 15th, there was short interest totalling 190,000 shares, a growth of 17.4% from the January 31st total of 161,900 shares. Based on an average daily trading volume, of 401,100 shares, the...\n more…